Indication and Usage :

1. Neuronox® 50 units is indicated for the treatment of benign essential blepharospasm in patients 18 years of age and older.

2. Neuronox® 50 units is indicated for the treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy patients 2 years of age and older.

3. Temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and/or procerus muscle activities in adults over the age of 20 and below the age of 65.

4. Muscle spasticity : Neuronox® 50 units is indicated for the treatment of upper limb spasticity associated with stroke in patient 20 years of age and older.